Civil Litigation,
Health Care & Hospital Law
Jul. 24, 2019
Allergan wins small verdict, less-than-punishing injunction against competitor
As pharmaceutical giant Allergan USA Inc. prepares to take its false advertisement action against rival compound drug maker Imprimis Pharmaceuticals Inc. to the 9th U.S. Circuit Court of Appeals, a federal judge ordered a less than punishing injunction against Imprimis.
As pharmaceutical giant Allergan USA Inc. prepares to take its false advertisement action against rival compound drug maker Imprimis Pharmaceuticals Inc. to the 9th U.S. Circuit Court of Appeals, a federal judge ordered a less than punishing injunction against Imprimis this week.
In what defense attorneys called a novel trial strategy to stifle competition from their San Diego client who sells a competing compounded eye therapy, A...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
